Treatment with LXR agonists after focal cerebral ischemia prevents brain damage

FEBS Letters

Volumn 582, Issue 23-24, 2008, Pages 3396-3400

  Sironi, Luigi ^b,c   Mitro, Nico ^a,b   Cimino, Mauro ^d   Gelosa, Paolo ^b   Guerrini, Uliano ^b   Tremoli, Elena ^b,c   Saez, Enrique ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c CENTRO CARDIOLOGICO MONZINO   (Italy)

^d UNIVERSITY OF URBINO   (Italy)

Author keywords

Acute cerebral ischemia; Experimental therapy; Neuroprotection; Nuclear receptor; Transcriptional activator

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORIMOTOR FUNCTION; SINGLE DRUG DOSE;

ANIMALS; BENZOIC ACIDS; BENZYLAMINES; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; LIGANDS; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 53049109169     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.08.035     Document Type: Article

References (23)

1. Rosamond W., et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
2. Goldstein L.B. Acute ischemic stroke treatment in 2007. Circulation 116 (2007) 1504-1514
3. Hoehn B.D., Palmer T.D., and Steinberg G.K. Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 36 (2005) 2718-2724
4. Kalaany N.Y., and Mangelsdorf D.J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Ann. Rev. Physiol. 68 (2006) 159-191
5. Zelcer N., and Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116 (2006) 607-614
6. Lefterov I., Bookout A., Wang Z., Staufenbiel M., Mangelsdorf D., and Koldamova R. Expression profiling in APP23 mouse brain: inhibition of Abeta amyloidosis and inflammation in response to LXR agonist treatment. Mol. Neurodegener. 2 (2007) 20 10.1186/1750-1326-2-20
7. Whitney K.D., et al. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16 (2002) 1378-1385
8. Zelcer N., Khanlou N., Clare R., Jiang Q., Reed-Geaghan E.G., Landreth G.E., Vinters H.V., and Tontonoz P. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc. Natl. Acad. Sci. USA 104 (2007) 10601-10606
9. Sironi L., et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 322-327
10. Tamura A., Graham D.I., McCullogh J., and Teasdale M.G. Focal cerebral ischemia in the rat: 1: description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1 (1981) 53-60
11. Villa P., et al. The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Mol. Med. 13 (2007) 125-133
12. Ciana P., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 25 (2006) 4615-4627
13. Cimino M., Gelosa P., Gianella A., Nobili E., Tremoli E., and Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist 13 (2007) 208-213
14. Guerrini U., Sironi L., Tremoli E., Cimino M., Pollo B., Calvio A.M., Paoletti R., and Asdente M. New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study. Stroke 33 (2002) 825-830
15. Walczak R., Joseph S.B., Laffitte B.A., Castrillo A., Pei L., and Tontonoz P. Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors. J. Biol. Chem. 279 (2004) 9905-9911
16. Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., and Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111 (2003) 1843-1851
17. Wang Y.Q., Guo X., Qiu M.H., Feng X.Y., and Sun F.Y. VEGF overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion. J. Neurosci. Res. 85 (2007) 73-82
18. Castrillo A., and Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Ann. Rev. Cell Dev. Biol. 20 (2004) 455-480
19. Castrillo A., Joseph S.B., Marathe C., Mangelsdorf D.J., and Tontonoz P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278 (2003) 10443-10449
20. Ghisletti S., Huang W., Ogawa S., Pascual G., Lin M.E., Willson T.M., Rosenfeld M.G., and Glass C.K. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25 (2007) 57-70
21. Joseph S.B., et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119 (2004) 299-309
22. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 (2003) 213-219
23. Kim O.S., Lee C.S., Joe E.H., and Jou I. Oxidized low density lipoprotein suppresses lipopolysaccharide-induced inflammatory responses in microglia: oxidative stress acts through control of inflammation. Biochem. Biophys. Res. Commun. 342 (2006) 9-18